MARKET

ENOV

ENOV

Enovis Corp
NYSE

Real-time Quotes | Nasdaq Last Sale

65.00
-1.27
-1.92%
After Hours: 65.00 0 0.00% 16:01 05/20 EDT
OPEN
66.94
PREV CLOSE
66.27
HIGH
67.49
LOW
63.84
VOLUME
373.14K
TURNOVER
0
52 WEEK HIGH
94.03
52 WEEK LOW
59.15
MARKET CAP
3.51B
P/E (TTM)
40.40
1D
5D
1M
3M
1Y
5Y
Recap: Enovis Q1 Earnings
  Enovis (NYSE:ENOV) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Enovis beat estimated earnings by 5.71%, reporting an EPS of $0.37 versus an estimate of $0.35.
Benzinga · 05/10 12:01
Enovis Q1 EPS $0.37 Beats $0.35 Estimate, Stand-Alone Sales $375M
Enovis (NYSE:ENOV) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.35 by 5.71 percent. This is a 71.97 percent decrease over earnings of $1.32 per share from the same period
Benzinga · 05/10 11:45
Enovis Corporation GAAP EPS of $0.33, revenue of $1.02B
Enovis Corporation press release (NYSE:ENOV): Q1 GAAP EPS of $0.33. Revenue of $1.02B (+16.0% Y/Y).
Seekingalpha · 05/10 11:19
BRIEF-Enovis Q1 Adjusted Earnings Per Share $0.37 From Continuing Operations
reuters.com · 05/10 11:13
Q1 2022 Earnings Preview
Enovis Corporation (NYSE:ENOV) is scheduled to announce Q1 earnings results on Tuesday, May 10th, before market open. The consensus EPS Estimate is $0.35 (-20.5% Y/Y) and the consensus Revenue Estimate
Seekingalpha · 05/09 17:40
Notable earnings before Tuesday's open
ACRS, AFCG, AGEN, AHCO, ALGM, AMRS, ANIP, ARMK, AROC, ARVL, ATNX, AUPH, AVYA, AZEK, OTCPK:BAYZF, BCO, BHC, BLDE, BLDR, BSY, CCO, CEVA, CHH, CMPS, CRNC, CRON, DBD, DCTH, DM, DS,
Seekingalpha · 05/09 15:06
--KeyBanc Downgrades Enovis to Sector Weight From Overweight
MT Newswires · 04/21 06:12
Enovis Schedules First Quarter 2022 Earnings Release and Conference Call
Wilmington, DE, April 14, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, today announced that it will issue a press release on the morning of Tuesday, M...
GlobeNewswire · 04/14 17:23
More
No Data
Learn about the latest financial forecast of ENOV. Analyze the recent business situations of Enovis Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

25.00%Strong Buy
25.00%Buy
50.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ENOV stock price target is 136.40 with a high estimate of 189.00 and a low estimate of 73.00.
High189.00
Average136.40
Low73.00
Current 65.00
EPS
Actual
Estimate
0.440.891.331.77
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 425
Institutional Holdings: 65.65M
% Owned: 121.50%
Shares Outstanding: 54.03M
TypeInstitutionsShares
Increased
145
10.48M
New
38
714.48K
Decreased
79
2.86M
Sold Out
56
1.96M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Industrial Machinery & Equipment
-0.52%
Machinery, Tools, Heavy Vehicles, Trains & Ships
-1.80%
Key Executives
Chairman/Director
Mitchell Rales
President/Chief Operating Officer/Director
Brady Shirley
Chief Executive Officer/Director
Matthew Trerotola
Chief Financial Officer/Executive Vice President - Finance
Christopher Hix
Chief Human Resource Officer/Senior Vice President
Patricia Lang
Executive Vice President
Shyam Kambeyanda
Executive Vice President
Daniel Pryor
Senior Vice President/General Counsel/Secretary
Bradley Tandy
Director
Barbara Bodem
Director
Angela Lalor
Director
Christine Ortiz
Independent Director
Liam Kelly
Independent Director
Philip Okala
Independent Director
A. Clayton Perfall
Independent Director
Rajiv Vinnakota
Independent Director
Sharon Wienbar
No Data
No Data
About ENOV
Colfax Corporation is a technology company. The Company provides orthopedic care and fabrication technology products and services. It operates through two segments: Fabrication Technology and Medical Technology. Fabrication Technology segment is a supplier of welding equipment, cutting equipment, automated welding and cutting systems, and consumables. Medical Technology segment is a provider of orthopedic solutions, providing orthopedic devices, software and services. Its fabrication technology products are marketed under the ESAB brand. ESAB's range of cutting and welding consumables includes electrodes, cored and solid wire and fluxes. The Company, through its subsidiary DJO Global, Inc. (DJO), provides medical devices that provide solutions for musculoskeletal health, vascular health and pain management. It also provides devices for fracture fixation, joint fusion and soft tissue injury repair. Its brands include Aircast, Chattanooga, Regeneration, COMPEX, DJO Surgical and PROCARE.

Webull offers kinds of Colfax Corp stock information, including NYSE:ENOV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENOV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ENOV stock methods without spending real money on the virtual paper trading platform.